This contract, which runs until 2033, covers the development, production, and testing of BiNOD binocular night vision devices for the U.S. Army. The contract was awarded in competition with five other bidders.

Jérôme Cerisier, CEO of Exosens, stated that this contract confirms the strength of the company's industrial strategy in the United States, particularly thanks to its production site in Sturbridge, Massachusetts.

This agreement marks a key milestone in Exosens' development within the U.S. defense market, strengthening its local industrial presence and supporting its long-term growth. An IDIQ contract sets a duration and a financial ceiling, but does not specify the exact volume or schedule of orders, which are placed incrementally via specific task orders. The announced amount is therefore a theoretical maximum and not a guaranteed revenue.